Changing the paradigm in the use of PSMA PET/CT in the primary assessment of newly diagnosed PCa can also meet the need for a fourth criteria of D’Amico, which allows a new risk group: very-high-risk PCa. This evidence concerns the gene FOLH1 and posterior cortical atrophy.